Phase 2, randomised trial to demonstrate the efficacy of linezolid in Korean patients with chronic extensively drug-resistant (XDR) pulmonary tuberculosis.
Phase of Trial: Phase II
Latest Information Update: 18 Aug 2015
At a glance
- Drugs Linezolid (Primary)
- Indications Pulmonary tuberculosis
- Focus Therapeutic Use
- 18 Aug 2015 New trial record